NDC product
Acetaminophen, Guaifenesin, Phenylephrine Hcl and Dextromethorphan HBr
NDC 35916-0166 · Softgel Healthcare Pvt Ltd
Key facts
| Product NDC | 35916-0166 |
|---|---|
| Proprietary name | Acetaminophen, Guaifenesin, Phenylephrine Hcl and Dextromethorphan HBr |
| Nonproprietary name | Acetaminophen, Guaifenesin, Phenylephrine Hcl and Dextromethorphan HBr |
| Substances | PHENYLEPHRINE HYDROCHLORIDE, DEXTROMETHORPHAN HYDROBROMIDE, ACETAMINOPHEN, GUAIFENESIN |
| Dosage form | CAPSULE, LIQUID FILLED |
| Route | ORAL |
| Labeler | Softgel Healthcare Pvt Ltd |
| Product type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Application number | M012 |
| Pharmacologic classes | Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA] and 3 more |
| Marketing start | Oct 29, 2024 |
| Listing certified through | Dec 31, 2027 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: